142 related articles for article (PubMed ID: 23915075)
1. Prognostic significance of mucinous differentiation of endometrioid adenocarcinoma of the endometrium.
Galic V; Schiavone MB; Herzog TJ; Holcomb K; Lewin SN; Lu YS; Neugut AI; Hershman DL; Wright JD
Cancer Invest; 2013 Aug; 31(7):500-4. PubMed ID: 23915075
[TBL] [Abstract][Full Text] [Related]
2. Mucinous Adenocarcinoma of the Endometrium Compared With Endometrioid Endometrial Cancer: A SEER Analysis.
Rauh-Hain JA; Vargas RJ; Clemmer J; Clark RM; Bradford LS; Growdon WB; Goodman A; Boruta DM; Schorge JO; del Carmen MG
Am J Clin Oncol; 2016 Feb; 39(1):43-8. PubMed ID: 24390270
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of lymphadenectomy and prevalence of lymph node metastasis in clinically-apparent stage I endometrioid and mucinous ovarian carcinoma.
Nasioudis D; Chapman-Davis E; Witkin SS; Holcomb K
Gynecol Oncol; 2017 Feb; 144(2):414-419. PubMed ID: 27908528
[TBL] [Abstract][Full Text] [Related]
4. Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey.
Lajer H; Elnegaard S; Christensen RD; Ortoft G; Schledermann DE; Mogensen O
Acta Obstet Gynecol Scand; 2012 Aug; 91(8):976-82. PubMed ID: 22548255
[TBL] [Abstract][Full Text] [Related]
5. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.
Bansal N; Herzog TJ; Seshan VE; Schiff PB; Burke WM; Cohen CJ; Wright JD
Obstet Gynecol; 2008 Jul; 112(1):64-70. PubMed ID: 18591309
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
Cosgrove CM; Cohn DE; Rhoades J; Felix AS
Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714
[TBL] [Abstract][Full Text] [Related]
7. Comparison of outcomes in patients with early-stage mucinous endometrial cancer and those with endometrioid endometrial cancer, with and without adjuvant therapy.
Owusu-Darko S; Rauh-Hain JA; Horowitz NS; Goodman A; Schorge JO; Del Carmen MG
J Reprod Med; 2014; 59(11-12):527-33. PubMed ID: 25552123
[TBL] [Abstract][Full Text] [Related]
8. Incidence and effects on mortality of venous thromboembolism in elderly women with endometrial cancer.
Rauh-Hain JA; Hariton E; Clemmer J; Clark RM; Hall T; Boruta DM; Schorge JO; Del Carmen MG
Obstet Gynecol; 2015 Jun; 125(6):1362-1370. PubMed ID: 26000507
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer.
Matsuo K; Machida H; Frimer M; Marcus JZ; Pejovic T; Roman LD; Wright JD
Gynecol Oncol; 2017 Dec; 147(3):558-564. PubMed ID: 28986093
[TBL] [Abstract][Full Text] [Related]
10. Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer.
Matsuo K; Matsuzaki S; Nusbaum DJ; Machida H; Nagase Y; Grubbs BH; Roman LD; Wright JD; Harter P; Klar M
Eur J Cancer; 2020 Jul; 133():33-46. PubMed ID: 32434109
[TBL] [Abstract][Full Text] [Related]
11. Mucinous differentiation does not impact stage or risk of recurrence among patients with grade 1, endometrioid type, endometrial carcinoma.
Worley MJ; Davis M; Berhie SH; Muto MG; Feltmate CM; Berkowitz RS; Horowitz NS; Campos SM
Gynecol Oncol; 2014 Oct; 135(1):54-7. PubMed ID: 25088333
[TBL] [Abstract][Full Text] [Related]
12. Atypical mucinous glandular proliferations in endometrial samplings: follow-up and other clinicopathological findings in 41 cases.
Rawish KR; Desouki MM; Fadare O
Hum Pathol; 2017 May; 63():53-62. PubMed ID: 28232161
[TBL] [Abstract][Full Text] [Related]
13. Is older age a poor prognostic factor in stage I and II endometrioid endometrial adenocarcinoma?
Fleming ND; Lentz SE; Cass I; Li AJ; Karlan BY; Walsh CS
Gynecol Oncol; 2011 Feb; 120(2):189-92. PubMed ID: 21112078
[TBL] [Abstract][Full Text] [Related]
14. Lymphadenectomy and prognosis for elderly females with stage I endometrioid endometrial cancer.
Zhao L; Li L; Ye Y; Han X; Fu X; Yu Y; Luo J
Arch Gynecol Obstet; 2019 Sep; 300(3):683-691. PubMed ID: 31256231
[TBL] [Abstract][Full Text] [Related]
15. Endometrioid endometrial carcinoma with atrophic endometrium and poor prognosis.
Geels YP; Pijnenborg JM; van den Berg-van Erp SH; Bulten J; Visscher DW; Dowdy SC; Massuger LF
Obstet Gynecol; 2012 Nov; 120(5):1124-31. PubMed ID: 23090531
[TBL] [Abstract][Full Text] [Related]
16. Impact on survival with adjuvant radiotherapy for clear cell, mucinous, and endometriod ovarian cancer: the SEER experience from 2004 to 2011.
Patel SC; Frandsen J; Bhatia S; Gaffney D
J Gynecol Oncol; 2016 Sep; 27(5):e45. PubMed ID: 27329193
[TBL] [Abstract][Full Text] [Related]
17. Ovarian Endometrioid Carcinoma Misdiagnosed as Mucinous Carcinoma: An Underrecognized Problem.
Woodbeck R; Kelemen LE; Köbel M
Int J Gynecol Pathol; 2019 Nov; 38(6):568-575. PubMed ID: 30480647
[TBL] [Abstract][Full Text] [Related]
18. Synchronous occurrence of primary neoplasms of the uterus with mucinous carcinoma of the cervix and endometrioid carcinoma of the endometrium.
Sun HD; Lai CR; Yen MS; Wang PH
Taiwan J Obstet Gynecol; 2011 Sep; 50(3):377-8. PubMed ID: 22030058
[No Abstract] [Full Text] [Related]
19. Patient compliance for postoperative radiotherapy and survival outcome of women with stage I endometrioid endometrial cancer.
Matsuo K; Machida H; Ragab OM; Garcia-Sayre J; Yessaian AA; Roman LD
J Surg Oncol; 2017 Sep; 116(4):482-491. PubMed ID: 28543055
[TBL] [Abstract][Full Text] [Related]
20. Villoglandular adenocarcinoma of the endometrium: a clinicopathologic study of 61 cases: a gynecologic oncology group study.
Zaino RJ; Kurman RJ; Brunetto VL; Morrow CP; Bentley RC; Cappellari JO; Bitterman P
Am J Surg Pathol; 1998 Nov; 22(11):1379-85. PubMed ID: 9808130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
